Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Eur Rev Med Pharmacol Sci ; 28(2): 577-583, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38305602

ABSTRACT

OBJECTIVE: This retrospective study explored the potential connection between adenomyosis and pregnancy outcomes. PATIENTS AND METHODS: A study included data from a total of 1,208 pregnancies. The adenomyosis group included 334 pregnant women with adenomyosis, and women in the control group (n=874) had uncomplicated pregnancies. Data on pregnancy complications and maternal and neonatal outcomes were compared. RESULTS: The incidence of gestational hypertension, gestational diabetes, and placenta previa was higher in the adenomyosis group compared to the control group (p<0.05). Adenomyosis was linked to a higher risk of postpartum hemorrhage (1,000-1,500 ml) but a lower risk of premature rupture of membranes (PROM) (p<0.05). Diagnosis of adenomyosis correlated with increased incidence of low fetal weight (20.3% vs. 21.3%, p<0.05) and a low APGAR score at 1 min (p<0.05). CONCLUSIONS: Adenomyosis correlated with a higher incidence of gestational hypertension, placenta previa, and gestational diabetes. At the same time, adenomyosis correlated with a significantly lower incidence of PROM compared to uncomplicated pregnancy. There was a significant increase in the incidence of postpartum hemorrhage and a higher risk of low fetal weight and lower APGAR score at 1 min in pregnancies with adenomyosis.


Subject(s)
Adenomyosis , Diabetes, Gestational , Hypertension, Pregnancy-Induced , Placenta Previa , Postpartum Hemorrhage , Infant, Newborn , Pregnancy , Female , Humans , Retrospective Studies , Adenomyosis/complications , Adenomyosis/epidemiology , Placenta Previa/epidemiology , Cohort Studies , Fetal Weight , Pregnancy Outcome/epidemiology , Diabetes, Gestational/epidemiology
3.
Cell Death Dis ; 4: e501, 2013 Feb 21.
Article in English | MEDLINE | ID: mdl-23429287

ABSTRACT

Many reports have shown that autophagy has a role as both a promoter and inhibitor in tumor development. However, the mechanism of this paradox is unknown. Tumor development is a multistep process. Therefore, we investigated whether the role of autophagy in hepatocarcinoma formation depended on the stage of tumor development. Based on our results, autophagy inhibition by chloroquine had a tumor-promotive effect in the rat model with N-diethylnitrosamine-induced hepatocarcinogenesis in its dysplastic stage (Ds) and a tumor-suppressive effect in its tumor-forming stage (Ts). In the Ds, autophagy inhibition enhanced cell proliferation, DNA damage and inflammatory cytokines expression in liver. These changes were dependent on the upregulation of reactive oxygen species (ROS) that was resulted from autophagy inhibition, and ultimately accelerated the process of hepatocarcinogenesis. However, in the Ts, autophagy inhibition restrained tumor formation by decreasing tumor cell survival and proliferation. In this stage, autophagy inhibition led to excessive ROS accumulation in the tumor, which promoted cell apoptosis, and prominently suppressed tumor cell metabolism. Taken together, our data suggested that autophagy suppressed hepatocarcinogenesis in the Ds by protecting normal cell stability and promoted hepatocarcinogenesis in the Ts by supporting tumor cells growth. Autophagy always had a role as a protector throughout the process of hepatocarcinoma development.


Subject(s)
Autophagy/drug effects , Carcinoma, Hepatocellular/chemically induced , Chloroquine/pharmacology , Liver Neoplasms/chemically induced , Protective Agents/pharmacology , Animals , Antioxidants/pharmacology , Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/prevention & control , Cell Proliferation/drug effects , Cell Transformation, Neoplastic/drug effects , Cytokines/metabolism , DNA Damage , Diethylnitrosamine/toxicity , Liver/metabolism , Liver Neoplasms/mortality , Liver Neoplasms/prevention & control , Male , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Survival Rate , Up-Regulation
4.
Clin Microbiol Infect ; 18(1): 74-80, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21767329

ABSTRACT

Nasopharyngeal aspirates were collected from 813 children ≤ 14 years old with acute lower respiratory tract infections in Lanzhou, China, from December 2006 to November 2009. PCR or RT-PCR was used to screen for the presence of 10 respiratory viruses. Viral agents were identified in 73.92% (601/813) of specimens, including RSV in 40.71%, hMPV in 6.15%, IFVA in 7.13%, IFVB in 0.98%, PIV1-3 in 7.87%, HCoV-HKU1 in 2.21%, HCoV-NL63 in 3.81%, HRV in 19.93%, AdV in 7.50% and HBoV in 11.56%. Two or more viruses were detected in 34.44% (280/813) of cases. The newly identified respiratory viruses, HBoV, hMPV, HCoV-HKU1 and HCoV-NL63, accounted for 22.01% of the detected viral pathogens. RSV and HRV were frequently detected in patients with bronchiolitis, and hMPV was frequently associated with pneumonia. HCoV-NL63 was found to be one of the causative agents of acute respiratory wheezing in young children. No seasonal variation was found in the incidence of detection of HCoV-HKU1, HCoV-NL63 or HBoV. This 3-year study demonstrated that viral pathogens play an important role in children with ALRTIs, and more attention should be paid to these newly identified viral agents.


Subject(s)
Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/virology , Virus Diseases/virology , Viruses/pathogenicity , Adolescent , Child , Child, Preschool , China , DNA, Viral/analysis , DNA, Viral/genetics , Female , Humans , Infant , Infant, Newborn , Male , RNA, Viral/analysis , RNA, Viral/genetics , Viruses/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...